See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2020_Regenerx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000707511, Regenerx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 681,555 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 30,205 |
| 4 | LiabilitiesCurrent | 242,473 |
| 5 | LiabilitiesNoncurrent | 2,101,325 |
| 6 | remainder_Liabilities | 708,070 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,284,993 |
| 9 | ResearchAndDevelopmentExpense | 70,341 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 77,244 |
| 12 | remainder_NetIncome | -228,501 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 711,760 |
| 1 | Liabilities | 3,051,868 |
| 2 | Expenses | 1,355,334 |
| 3 | Revenues | 77,244 |
| 4 | StockholdersEquity | -2,340,108 |
| 5 | NetIncome | -1,506,591 |
| 6 | ComprehensiveNetIncome | -1,506,591 |
| 7 | BaseVar | 2,712,354 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.51 |
| 9 | EconomicCapitalRatio | 0.526 |
Edgar->Model Mapping
Feature Distribution
Change over Time
